Literature DB >> 33919144

Importance of Geospatial Heterogeneity in Chronic Disease Burden for Policy Planning in an Urban Setting Using a Case Study of Singapore.

Ken Wei Tan1, Joel R Koo1, Jue Tao Lim1, Alex R Cook1, Borame L Dickens1.   

Abstract

Chronic disease burdens continue to rise in highly dense urban environments where clustering of type II diabetes mellitus, acute myocardial infarction, stroke, or any combination of these three conditions is occurring. Many individuals suffering from these conditions will require longer-term care and access to clinics which specialize in managing their illness. With Singapore as a case study, we utilized census data in an agent-modeling approach at an individual level to estimate prevalence in 2020 and found high-risk clusters with >14,000 type II diabetes mellitus cases and 2000-2500 estimated stroke cases. For comorbidities, 10% of those with type II diabetes mellitus had a past acute myocardial infarction episode, while 6% had a past stroke. The western region of Singapore had the highest number of high-risk individuals at 173,000 with at least one chronic condition, followed by the east at 169,000 and the north with the least at 137,000. Such estimates can assist in healthcare resource planning, which requires these spatial distributions for evidence-based policymaking and to investigate why such heterogeneities exist. The methodologies presented can be utilized within any urban setting where census data exists.

Entities:  

Keywords:  chronic disease; environmental health; spatial epidemiology; statistical modeling; urbanization

Year:  2021        PMID: 33919144     DOI: 10.3390/ijerph18094406

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  25 in total

1.  The relative merits of population-based and targeted prevention strategies.

Authors:  Donna M Zulman; Sandeep Vijan; Gilbert S Omenn; Rodney A Hayward
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

2.  Understanding evidence-based public health policy.

Authors:  Ross C Brownson; Jamie F Chriqui; Katherine A Stamatakis
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

3.  Health geography: supporting public health policy and planning.

Authors:  Trevor J B Dummer
Journal:  CMAJ       Date:  2008-04-22       Impact factor: 8.262

4.  Computing disease incidence, prevalence and comorbidity from electronic medical records.

Authors:  Steven C Bagley; Russ B Altman
Journal:  J Biomed Inform       Date:  2016-08-04       Impact factor: 6.317

5.  Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010.

Authors:  Kate Smolina; F Lucy Wright; Mike Rayner; Michael J Goldacre
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-06-26

6.  Recent Advances in Computational Epidemiology.

Authors:  Madhav Marathe; Naren Ramakrishnan
Journal:  IEEE Intell Syst       Date:  2013-07       Impact factor: 3.405

7.  The Canadian Urban Environmental Health Research Consortium - a protocol for building a national environmental exposure data platform for integrated analyses of urban form and health.

Authors:  Jeffrey R Brook; Eleanor M Setton; Evan Seed; Mahdi Shooshtari; Dany Doiron
Journal:  BMC Public Health       Date:  2018-01-08       Impact factor: 3.295

8.  Relationship between social engagement and diabetes incidence in a middle-aged population: Results from a longitudinal nationwide survey in Japan.

Authors:  Taiga Shibayama; Haruko Noguchi; Hideto Takahashi; Nanako Tamiya
Journal:  J Diabetes Investig       Date:  2018-03-23       Impact factor: 4.232

9.  Methodology Series Module 3: Cross-sectional Studies.

Authors:  Maninder Singh Setia
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

10.  Emergency department crowding: A systematic review of causes, consequences and solutions.

Authors:  Claire Morley; Maria Unwin; Gregory M Peterson; Jim Stankovich; Leigh Kinsman
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.